Utah Medical Products Reports Double-Digit Q1 Revenue and EPS Decline

summarizeSummary

Utah Medical Products, Inc. reported a 10.2% decline in Q1 2026 revenue and an 11.0% drop in EPS, primarily due to lost distributor and OEM sales, though results were consistent with prior projections.

check_boxKey Events

• Revenue Decline

  Consolidated sales decreased by 10.2% to $8.722 million in Q1 2026 compared to $9.710 million in Q1 2025.

• EPS Drop

  Diluted Earnings Per Share (EPS) fell by 11.0% to $0.818 in Q1 2026 from $0.919 in Q1 2025.

• Profitability Impact

  Operating Income declined 18.7% and Net Income dropped 14.4% year-over-year.

• Sales Drivers

  The decline was largely attributed to the absence of sales to a former China distributor and an OEM customer, which accounted for 87% of the lower sales.

auto_awesomeAnalysis

Utah Medical Products, Inc. reported a significant decline in its first-quarter 2026 financial performance, with revenue dropping 10.2% and EPS falling 11.0%. These results continue a negative trend, primarily driven by the cessation of sales to a major China distributor and an OEM customer. While the company stated these results were consistent with prior projections, the magnitude of the decline is notable. However, the company's balance sheet remains strong with increased cash and ongoing share repurchases, which helped mitigate the EPS impact. Investors should monitor future sales performance and the impact of litigation expenses.